Literature DB >> 3011897

Oxidative inactivation of pneumolysin by the myeloperoxidase system and stimulated human neutrophils.

R A Clark.   

Abstract

Pneumolysin, a hemolytic toxin from Streptococcus pneumoniae, is a member of the group of thiol-activated, oxygen-labile cytolysins produced by various Gram-positive bacteria. The toxin activity of pneumolysin, as determined by lysis of 51Cr-labeled human erythrocytes, was destroyed on exposure to the neutrophil enzyme myeloperoxidase, hydrogen peroxide, and a halide (chloride or iodide). Detoxification required each component of the myeloperoxidase system and was prevented by the addition of agents that inhibit heme enzymes (azide, cyanide) or degrade H2O2 (catalase). Reagent H2O2 could be replaced by the peroxide-generating enzyme system glucose oxidase plus glucose. The entire myeloperoxidase system could be replaced by sodium hypochlorite at micromolar concentrations. Toxin inactivation was a function of time of exposure to the myeloperoxidase system (less than 1 min), the rate of formation of H2O2 (0.05 nmol/min), and the concentration of toxin employed. Toxin that had been inactivated by the myeloperoxidase system was reactivated on incubation with the reducing agent dithiothreitol. Pneumolysin was also inactivated when incubated with human neutrophils (10(5)) in the presence of a halide and phorbol myristate acetate, an activator of neutrophil secretion and oxygen metabolism. Toxin inactivation by stimulated neutrophils was blocked by azide, cyanide, or catalase, but not by superoxide dismutase. Neutrophils from patients with impaired oxygen metabolism (chronic granulomatous disease) or absent myeloperoxidase (hereditary deficiency) failed to inactivate the toxin unless they were supplied with an exogenous source of H2O2 or purified myeloperoxidase, respectively. Thus, inactivation of pneumolysin involved the secretion of myeloperoxidase and H2O2, which combined with extracellular halides to form agents (e.g., hypochlorite) capable of oxidizing the toxin. This example of oxidative inactivation of a cytolytic agent may serve as a model for phagocyte-mediated detoxification of microbial products.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3011897

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  7 in total

1.  Receptor-dependent and -independent immunomodulatory effects of phenol-soluble modulin peptides from Staphylococcus aureus on human neutrophils are abrogated through peptide inactivation by reactive oxygen species.

Authors:  Huamei Forsman; Karin Christenson; Johan Bylund; Claes Dahlgren
Journal:  Infect Immun       Date:  2012-03-19       Impact factor: 3.441

Review 2.  Contributions of myeloperoxidase to proinflammatory events: more than an antimicrobial system.

Authors:  W M Nauseef
Journal:  Int J Hematol       Date:  2001-08       Impact factor: 2.490

Review 3.  The many roles of NOX2 NADPH oxidase-derived ROS in immunity.

Authors:  Grace Y Lam; Ju Huang; John H Brumell
Journal:  Semin Immunopathol       Date:  2010-08-28       Impact factor: 9.623

4.  Oxidation of proteins in rat heart and lungs by polymorphonuclear leukocyte oxidants.

Authors:  H Fliss
Journal:  Mol Cell Biochem       Date:  1988-12       Impact factor: 3.396

5.  Characterisation of an oxidative response inhibitor produced by Streptococcus pneumoniae.

Authors:  F E Perry; C J Elson; T J Mitchell; P W Andrew; J R Catterall
Journal:  Thorax       Date:  1994-07       Impact factor: 9.139

6.  Pneumolysin activates macrophage lysosomal membrane permeabilization and executes apoptosis by distinct mechanisms without membrane pore formation.

Authors:  Martin A Bewley; Michael Naughton; Julie Preston; Andrea Mitchell; Ashleigh Holmes; Helen M Marriott; Robert C Read; Timothy J Mitchell; Moira K B Whyte; David H Dockrell
Journal:  MBio       Date:  2014-10-07       Impact factor: 7.867

7.  Hydrogen peroxide release by bacteria suppresses inflammasome-dependent innate immunity.

Authors:  Saskia F Erttmann; Nelson O Gekara
Journal:  Nat Commun       Date:  2019-08-02       Impact factor: 14.919

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.